Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Immuno Cure BioTech (2163385D CH)
Watchlist
1
Analysis
Health Care
•
Hong Kong
Immuno Cure BioTech Limited medical technology development businesses. The Company develops gene vaccines, antibody drugs, and other products. Immuno Cure BioTech conducts businesses in China and Hong Kong.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Immuno Cure BioTech
•
02 Aug 2023 11:28
•
Syndicated
Immuno Cure Bags US$12M Series A Funding, Gears up for Hong Kong IPO
Hong Kong-based Immuno Cure BioTech has closed the US$12 million tranche of its US$27 million Series A fundraising round, led by Gobi Partners...
e27
Follow
230 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.35.0
x